1. Efficacy and safety of switching to raltegravir plus atazanavir dual therapy in pretreated HIV-1-infected patients over 144 weeks: a cohort study. (December 2014) Authors: Gantner, Pierre; Koeppel, Christine; Partisani, Marialuisa; Batard, Marie-Laure; Bernard-Henry, Claudine; Cheneau, Christine; De Mautort, Erik; Priester, Michele; Muret, Patrice; Sueur, Charlotte; Fafi-Kremer, Samira; Rey, David Journal: Scandinavian journal of infectious diseases Issue: Volume 46:Number 12(2014:Dec.) Page Start: 838 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗